BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PDX1
,
G-protein-coupled receptor binding
,
Allergy to pollen
,
Pancreas
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RNA cap binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Pyloric ulcer
Injury of eye region
Barrett's esophagus
Caseating tuberculoid granuloma
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
enterotoxin F, Staphylococcal
CGP 60474
Apitolisib
OTS-167
GSK-1059615
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PLEKHG6
GRHPR
CD46
FN1
TLK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Host factor Ebp1: selective inhibitor of influenza virus transcriptase.
Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA pol…
eIF-4E expression is associated with histopathologic grades in cervical neoplasia.
Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to h…
Purification of the messenger RNA cap-binding protein using a new affinity medium.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Leukocyte Morphological Parameters as Prognostic Markers in CAP
Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autolog…
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Pat…
The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors
A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing M…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ